Simplify Logo

Full-Time

Senior Solution Architect

Confirmed live in the last 24 hours

Tempus

Tempus

1,001-5,000 employees

AI-driven healthcare data analysis platform

AI & Machine Learning
Biotechnology
Healthcare

Senior, Expert

Chicago, IL, USA

Category
Solution Engineering
Sales & Solution Engineering
Required Skills
Python
Sales
Data Science
R
Requirements
  • Advanced degree (Masters or PhD) in bioinformatics, computational biology, statistics, computer science, or related field, or 3+ years experience working with genomic and clinical data
  • Experience working with statistical modeling, data mining and/or machine learning methods
  • Proficiency in R or python and/or other programming languages
  • Strong project management and post-sales skills: understanding and qualifying customer requirements, supporting customers in making progress against a roadmap, aligning scientific results with business outcomes
  • Demonstrated ability to communicate technical concepts to non-technical stakeholders
Responsibilities
  • As a solution architect on the Lens team at Tempus, you’ll be on the front lines of our collaborations with external partners, helping guide customers through using the Lens platform to apply cutting-edge data science techniques to unique cancer datasets.
  • You will be engaged with customers throughout their time working with Lens, including training and onboarding, filtering for data of interest, and design and implementation of customer data science and analytical use cases.
  • Our solution architects should be comfortable on a whiteboard designing a pilot or in a board room with an Executive, providing trusted technical advice for our partners and clients.

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in the healthcare sector. The company offers a platform that analyzes medical data, helping physicians make better treatment decisions by providing insights from medical images and identifying care gaps. For pharmaceutical and biotech companies, Tempus aids in drug development by discovering new targets and assessing treatment effectiveness. Patients benefit from personalized therapy options identified through the platform. Tempus conducts significant research, particularly in cancer, and has developed tools like a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. The company generates revenue by charging healthcare providers and companies for access to its platform and insights.

Company Stage

Series G

Total Funding

$1.3B

Headquarters

Chicago, Illinois

Founded

2015

Growth & Insights
Headcount

6 month growth

5%

1 year growth

12%

2 year growth

36%
Simplify Jobs

Simplify's Take

What believers are saying

  • Tempus's IPO and significant revenue generation indicate strong financial health and growth potential.
  • Collaborations with industry giants like SoftBank and United Therapeutics can lead to groundbreaking advancements and increased market share.
  • The company's focus on personalized therapy and AI-driven insights can significantly improve patient outcomes, making it a rewarding place to work for those passionate about healthcare innovation.

What critics are saying

  • The lawsuit from Guardant Health over patent infringement could result in financial and reputational damage.
  • Operating in a highly competitive market with peers like Foundation Medicine and Guardant Health requires continuous innovation to maintain a competitive edge.

What makes Tempus unique

  • Tempus leverages AI to provide actionable insights from medical data, setting it apart from competitors who may not integrate AI as deeply into their platforms.
  • Their focus on personalized therapy options and extensive cancer research, including a pan-cancer organoid platform and liquid biopsy assay, distinguishes them in the healthcare tech space.
  • Tempus's collaboration with major firms like SoftBank and United Therapeutics highlights its strong industry partnerships and credibility.